Active Biotech: Laquinimod Enters Vitreous Body - Redeye
Bildkälla: Stockfoto

Active Biotech: Laquinimod Enters Vitreous Body - Redeye

Redeye is encouraged by the results from the LION study, demonstrating penetration of laquinimod into the human eye’s vitreous body and likely the posterior parts. We revise our base case.

Redeye is encouraged by the results from the LION study, demonstrating penetration of laquinimod into the human eye’s vitreous body and likely the posterior parts. We revise our base case.
Börsvärldens nyhetsbrev